Search Results - "Balduzzi, Silvia"

Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis by Favalli, Ennio Giulio, Bugatti, Serena, Klersy, Catherine, Biggioggero, Martina, Rossi, Silvia, De Lucia, Orazio, Bobbio-Pallavicini, Francesca, Murgo, Antonella, Balduzzi, Silvia, Caporali, Roberto, Montecucco, Carlomaurizio

“…Prevalence and outcomes of coronavirus disease (COVID)-19 in relation to immunomodulatory medications are still unknown. The aim of the study is to investigate…”
Get full text

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies by Monti, Sara, Balduzzi, Silvia, Delvino, Paolo, Bellis, Elisa, Quadrelli, Verdiana Serena, Montecucco, Carlomaurizio

Get more information

Incidence of COVID‐19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data? by Favalli, Ennio Giulio, Monti, Sara, Ingegnoli, Francesca, Balduzzi, Silvia, Caporali, Roberto, Montecucco, Carlomaurizio

“…Objective To describe the incidence and severity of coronavirus disease 2019 (COVID‐19) in patients with rheumatic diseases treated with targeted synthetic or…”
Get full text

The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature by Delvino, Paolo, Monti, Sara, Balduzzi, Silvia, Belliato, Mirko, Montecucco, Carlomaurizio, Caporali, Roberto

“…Diffuse alveolar haemorrhage (DAH) secondary to anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is a rare life-threatening condition…”
Get full text

Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease by Ruscitti, Piero, Natoli, Valentina, Consolaro, Alessandro, Caorsi, Roberta, Rosina, Silvia, Giancane, Gabriella, Naddei, Roberta, Di Cola, Ilenia, Di Muzio, Claudia, Berardicurti, Onorina, Iacono, Daniela, Pantano, Ilenia, Rozza, Gelsomina, Rossi, Silvia, De Stefano, Ludovico, Balduzzi, Silvia, Vitale, Antonio, Caso, Francesco, Costa, Luisa, Prete, Marcella, Navarini, Luca, Iagnocco, Annamaria, Atzeni, Fabiola, Guggino, Giuliana, Perosa, Federico, Cantarini, Luca, Frediani, Bruno, Montecucco, Carlomaurizio, Ciccia, Francesco, Cipriani, Paola, Gattorno, Marco, Giacomelli, Roberto, Ravelli, Angelo

“…Abstract Objective To compare clinical features and treatments of patients with systemic JIA (sIJA) and adult-onset Still’s disease (AOSD). Methods The…”
Get full text

Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study by Sarzi-Puttini, Piercarlo, Marotto, Daniela, Caporali, Roberto, Montecucco, Carlo Maurizio, Favalli, Ennio Giulio, Franceschini, Franco, Fredi, Michela, Balduzzi, Silvia, Bazzani, Chiara, Bongiovanni, Sara, Giorgi, Valeria, Batticciotto, Alberto, Cappelli, Antonella, Balzarini, Patrizia, Dagna, Lorenzo, Sartorelli, Silvia, Ravagnani, Viviana, Tamanini, Silvia, Farah, Sonia, Faggioli, Paola, Castelnovo, Laura, Lurati, Alfredo Maria, Galli, Massimo, Salaffi, Fausto

“…The COVID-19 pandemic has raised questions about the management of systemic immunosuppressive treatments for rheumatic conditions. It is well known that…”
Get full text

Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs by De Stefano, Ludovico, Balduzzi, Silvia, Bogliolo, Laura, D'Onofrio, Bernardo, di Lernia, Michele, Mauric, Eleonora, Milanesi, Alessandra, Brandolino, Fabio, Rocca, Clarissa, Chiricolo, Sofia, Manzo, Antonio, Montecucco, Carlomaurizio, Bugatti, Serena

“…The safety of COVID-19 vaccination in rheumatic patients treated with biological (b) and targeted synthetic (ts) disease-modifying anti-rheumatic drugs…”
Get more information

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors by Quartuccio, Luca, Bond, Milena, Isola, Miriam, Monti, Sara, Felicetti, Mara, Furini, Federica, Murgia, Stefano, Berti, Alvise, Silvestri, Elena, Pazzola, Giulia, Bozzolo, Enrica, Leccese, Pietro, Raffeiner, Bernd, Parisi, Simone, Leccese, Ilaria, Cianci, Francesco, Bettio, Silvano, Sainaghi, Pierpaolo, Ianniello, Aurora, Ravagnani, Viviana, Bellando Randone, Silvia, Faggioli, Paola, Lomater, Claudia, Stobbione, Paolo, Ferro, Francesco, Colaci, Michele, Alfieri, Giuseppina, Carubbi, Francesco, Erre, Gian Luca, Giollo, Alessandro, Franzolini, Nicoletta, Ditto, Maria Chiara, Balduzzi, Silvia, Padoan, Roberto, Bortolotti, Roberto, Bortoluzzi, Alessandra, Cariddi, Adriana, Padula, Angela, Di Scala, Gerardo, Gremese, Elisa, Conti, Fabrizio, D'Angelo, Salvatore, Matucci Cerinic, Marco, Dagna, Lorenzo, Emmi, Giacomo, Salvarani, Carlo, Paolazzi, Giuseppe, Roccatello, Dario, Govoni, Marcello, Schiavon, Franco, Caporali, Roberto, De Vita, Salvatore

“…Alveolar haemorrhage (AH) is considered an important cause of morbidity and early mortality in anti-neutrophil cytoplasmic antibodies (ANCA)-associated…”
Get full text

Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis by Bruni, Cosimo, Ngcozana, Tanaka, Braschi, Francesca, Pucci, Tiziana, Piemonte, Guya, Benelli, Laura, Poli, Melissa, Suliman, Yossra A, Guiducci, Serena, Bellando-Randone, Silvia, Balduzzi, Silvia, Grotts, Jonathan, Denton, Christopher P, Rasero, Laura, Montecucco, CarloMaurizio, Furst, Daniel E, Matucci-Cerinic, Marco

“…To date, "healed/non-healed" and clinical judgment are the only available assessment tools for digital ulcers (DU) in patients with systemic sclerosis (SSc)…”
Get full text

Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study by Ruscitti, Piero, Di Cola, Ilenia, Berardicurti, Onorina, Conforti, Alessandro, Iacono, Daniela, Pantano, Ilenia, Rozza, Gelsomina, Rossi, Silvia, De Stefano, Ludovico, Balduzzi, Silvia, Vitale, Antonio, Caso, Francesco, Costa, Luisa, Prete, Marcella, Navarini, Luca, Atzeni, Fabiola, Guggino, Giuliana, Perosa, Federico, Cantarini, Luca, Frediani, Bruno, Montecucco, Carlomaurizio, Ciccia, Francesco, Giacomelli, Roberto, Cipriani, Paola

“…The objective of this study is to describe the possible prognostic impact of smoking habit on adult-onset Still’s disease (AOSD) patients, by the assessment of…”
Get full text

Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA by Iannone, Florenzo, Favalli, Ennio G., Caporali, Roberto, D’Angelo, Salvatore, Cantatore, Francesco Paolo, Sarzi-Puttini, Piercarlo, Foti, Rosario, Conti, Fabrizio, Carletto, Antonio, Gremese, Elisa, Cauli, Alberto, Ramonda, Roberta, Palermo, Adalgisa, Epis, Oscar, Priora, Marta, Bergossi, Francesca, Frediani, Bruno, Salaffi, Fausto, Lopalco, Giuseppe, Cacciapaglia, Fabio, Marchesoni, Antonio, Biggioggiero, Martina, Bugatti, Serena, Balduzzi, Silvia, Carriero, Antonio, Corrado, Addolorata, Bongiovanni, Sara, Benenati, Alessia, Miranda, Francesca, Fracassi, Elena, Perra, Daniela, Ferraccioli, Gianfranco, Lapadula, Giovanni

“…•In a large cohort of patients with SpA and PsA from the real life, golimumab has shown to be as effective in 1-biologic IR as in biologic-naive patients, with…”
Get full text

Correction to: Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study by Ruscitti, Piero, Di Cola, Ilenia, Berardicurti, Onorina, Conforti, Alessandro, Iacono, Daniela, Pantano, Ilenia, Rozza, Gelsomina, Rossi, Silvia, De Stefano, Ludovico, Balduzzi, Silvia, Vitale, Antonio, Caso, Francesco, Costa, Luisa, Prete, Marcella, Navarini, Luca, Atzeni, Fabiola, Guggino, Giuliana, Perosa, Federico, Cantarini, Luca, Frediani, Bruno, Montecucco, Carlomaurizio, Ciccia, Francesco, Giacomelli, Roberto, Cipriani, Paola

Get full text

In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols by Balduzzi, Silvia, Scirè, Carlo Alberto, Sakellariou, Garifallia, Benaglio, Francesca, Bugatti, Serena, Montecucco, Carlomaurizio, Caporali, Roberto

“…The aim of this study was to compare the 12-month probability of remission in early inflammatory arthritis with a milder treatment based on the 1987 criteria…”
Get full text

Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry by Sebastiani, Marco, Venerito, Vincenzo, Bugatti, Serena, Bazzani, Chiara, Biggioggero, Martina, Petricca, Luca, Foti, Rosario, Bortoluzzi, Alessandra, Balduzzi, Silvia, Visalli, Elisa, Frediani, Bruno, Manfredi, Andreina, Gremese, Elisa, Favalli, Ennio, Iannone, Florenzo, Ferraccioli, Gianfranco, Lapadula, Giovanni

“…Objectives EULAR recommendations do not suggest which biologic disease-modifying anti-rheumatic drug (bDMARD) should be preferred after failure of a first…”
Get full text